Corbus Pharmaceuticals Holdings Inc. Stock Rises 4.4%, Outperforms Peers
Dow Jones2026/08/07 20:35This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. rallied 4.4% to $10.17 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.3% to 26,690.62 and the Dow Jones Industrial Average rising 0.3% to 54,036.93.
This was the stock's fourth consecutive day of gains.
Corbus Pharmaceuticals Holdings Inc. closed 50.5% short of its 52-week high of $20.56, which the company reached on October 20th.
The stock outperformed some of its peers, as Vanda Pharmaceuticals Inc. fell 2.2% to $5.00, Fortress Biotech Inc. fell 3.6% to $2.67, and Viking Therapeutics Inc. rose 2.88% to $34.26.
Trading volume totaled 352,885, compared to the 50-day average of 447,114.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 07, 2026 16:35 ET (20:35 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
OpenAI enterprise business shows "strong momentum," CFO: 32% month-on-month growth in July
According to media reports, OpenAI CFO Sarah Friar stated that the company's enterprise business has performed "very strongly" recently; OpenAI's overall annualized revenue run rate in July increased by 20% compared to the previous month, with enterprise business up 32% month-on-month, outpacing the growth of personal consumer business.
Elastic CTO Shay Banon reports disposal of Elastic common shares worth $26.79 million
Progressive Planet Solutions Names Kyle Dickson Interim CFO, Adds Dave Barnett to Board
Crypto prices
More
